Treatment of basal cell carcinoma with intralesional interferon. 1986

H T Greenway, and R C Cornell, and D J Tanner, and E Peets, and G M Bordin, and C Nagi

Eight patients with basal cell carcinomas were treated with recombinant alpha-2 interferon. Each patient had a biopsy-proved basal cell carcinoma of the nodular or superficial type that was injected intralesionally three times a week for 3 weeks (9 total injections) with 1.5 X 10(6) IU (0.15 ml) of alpha-2 interferon per injection (total dose, 13.5 X 10(6) IU). Excisional biopsy 2 months after completion of therapy revealed no evidence of basal cell carcinoma in any patient. Minimal side effects were observed. In these eight patients alpha-2 interferon was therefore an effective and safe modality of treatment. The encouraging results of this pilot study suggest that additional evaluation of interferon in the treatment of basal cell carcinoma is warranted.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002280 Carcinoma, Basal Cell A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471) Carcinoma, Basal Cell, Pigmented,Epithelioma, Basal Cell,Rodent Ulcer,Ulcer, Rodent,Basal Cell Carcinoma,Basal Cell Carcinomas,Basal Cell Epithelioma,Basal Cell Epitheliomas,Carcinomas, Basal Cell,Epitheliomas, Basal Cell,Rodent Ulcers,Ulcers, Rodent
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm

Related Publications

H T Greenway, and R C Cornell, and D J Tanner, and E Peets, and G M Bordin, and C Nagi
January 1993, The Australasian journal of dermatology,
H T Greenway, and R C Cornell, and D J Tanner, and E Peets, and G M Bordin, and C Nagi
January 1994, The Australasian journal of dermatology,
H T Greenway, and R C Cornell, and D J Tanner, and E Peets, and G M Bordin, and C Nagi
May 1995, The New Zealand medical journal,
H T Greenway, and R C Cornell, and D J Tanner, and E Peets, and G M Bordin, and C Nagi
September 1991, Journal of the Royal Society of Medicine,
H T Greenway, and R C Cornell, and D J Tanner, and E Peets, and G M Bordin, and C Nagi
January 1990, Acta dermato-venereologica,
H T Greenway, and R C Cornell, and D J Tanner, and E Peets, and G M Bordin, and C Nagi
January 1992, Journal of the American Academy of Dermatology,
H T Greenway, and R C Cornell, and D J Tanner, and E Peets, and G M Bordin, and C Nagi
October 1989, Journal of the American Academy of Dermatology,
H T Greenway, and R C Cornell, and D J Tanner, and E Peets, and G M Bordin, and C Nagi
July 1994, Journal of the American Academy of Dermatology,
H T Greenway, and R C Cornell, and D J Tanner, and E Peets, and G M Bordin, and C Nagi
April 2010, Journal of drugs in dermatology : JDD,
H T Greenway, and R C Cornell, and D J Tanner, and E Peets, and G M Bordin, and C Nagi
January 1990, Archives of dermatological research,
Copied contents to your clipboard!